Hepatic Elimination of Drugs in Gestational Diabetes.
CONCLUSION: Considering the frequency of the disease and the effects that these pharmacokinetic changes might have on the mother and child, the need for further research seems advisable. In the meantime, cautious clinical judgment in the management of drug administration in women affected by this disease is recommended.
PMID: 29577863 [PubMed - as supplied by publisher]
Source: Current Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Gonzalez CD, Alvarinas J, Bolanos R, Di Girolamo G Tags: Curr Clin Pharmacol Source Type: research
More News: Alcoholism | Chemistry | Children | Databases & Libraries | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Hypertension | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Pregnancy | Study | Urology & Nephrology | Women